A cluster brings the supply chain together
On 21 May 2024, Spain’s agriculture secretary Begoña García attended the presentation of the Industrial Hemp Cluster in Madrid. The organisation brought together companies and growers working across agriculture and industries including construction, plastics and pharmaceuticals. The ministry highlighted demand for bioplastics, biocomposites and construction applications. This was a concrete step towards connecting agricultural material with industrial customers: a field produces a raw material, while processing and manufacturing turn it into products with different specifications and uses.
Textiles, insulation and composites
The European Commission identifies several established hemp applications. Fibre can enter textiles and paper; building products include hemp–lime concrete, hemp wool and fibreboard insulation. Composites offer another route into manufactured components. These products require different processing equipment and purchasers. A textile manufacturer buys a suitable fibre, while an insulation producer needs material that works within a building product. Economic value therefore accumulates through preparation, processing, manufacturing and distribution, rather than arising solely from the amount harvested.
Why coordination matters
The cluster’s combination of growers and companies addresses a practical link in that chain: agricultural supply needs an industrial destination, and processors need material suited to their production. Logistics, processing capacity and product specifications determine whether those links work. At the May presentation, the ministry also acknowledged confusion over legal interpretations and described its information work on permitted purposes and obligations. That uncertainty affects how businesses organise supply and plan facilities. The ministry’s own remit in the announcement concerned industrial hemp for fibre, a narrower activity than the whole cannabis economy.
Medical reform followed a different timetable
On 30 September 2024, the Health Ministry published a draft decree on standardised cannabis preparations for therapeutic use. Its economic significance lay in a pharmaceutical pathway, with quality controls and regulated preparations, rather than the fibre and construction chain. The framework was subsequently adopted through Royal Decree 903/2025: the 2024 announcement was still a proposal. Medical production links manufacturers, analytical testing and pharmaceutical services; hemp materials link processors to industrial buyers. Spain’s opportunities in 2024 centred on developing these specialised chains, each with its own customers, technical requirements and regulatory timetable.
[3] Health Ministry — 2024 announcements[4] BOE — Royal Decree 903/2025
Sources & further reading
General information, not individual legal or medical advice.